US Pharma Industry Shifts Towards Chinese Science
The United States has seen a significant shift in clinical drug development and supply chain towards China, according to a June Cure Innovation Index survey. This change is evident as Big Pharma signs billion-dollar deal
2d agopharmaceuticalschina